Anterix (ATEX) Director Leslie B. Daniels Sells Shares

What Happened
Leslie B. Daniels, a director of Anterix, reported open-market sales of a total of 10,100 shares of ATEX stock on Sept. 3–4, 2026. The three reported transactions were: 6,000 shares at $87.15 ($522,900), 2,900 shares at $87.31 ($253,200), and 1,200 shares at $86.50 ($103,800), for aggregate proceeds of approximately $879,900. These were outright sales (transaction code S), which are typically routine disposals rather than bullish signals.

Key Details

• Transaction dates: Sept 3, 2026 (6,000 shares) and Sept 4, 2026 (2,900 and 1,200 shares).
• Prices reported: $87.15, $87.31, and $86.50; total proceeds ≈ $879,900.
• Total shares sold: 10,100.
• Shares owned after transaction: Not specified in the provided filing.
• Footnotes: The filing includes weighted-average pricing notes indicating sales occurred in multiple executions within reported price ranges; the reporting person will provide a per-price breakdown upon request (see Footnotes F1 and F2).
• Timeliness: Form 4 was filed Sept. 8, 2026 for transactions on Sept. 3–4—this is outside the usual 2-business-day reporting window and appears to be a late filing.

Context

• These were direct sales of shares (code S). Sales by insiders can be for many reasons (diversification, tax/liquidity needs, scheduled plans) and do not by themselves indicate company performance.
• The filing does not indicate a 10% owner status or option exercises related to these transactions.